A 12-week treatment for eosinophilic esophagitis (EoE) in patients 11 years of age and older. EOHILIA has not been shown to be safe and effective for longer than 12 weeks.1

Subscribe to updates about EOHILIA™


Stay in the loop

Subscribe to updates about EOHILIA

All fields are required except those marked optional.


  1. EOHILIA (budesonide oral suspension) Prescribing Information. Takeda Pharmaceuticals, Inc.